A The inclusion of genetic tests for breast cancer in the Unified Health System (SUS) is becoming a reality in Goiás, setting an important precedent for the rest of Brazil. A Brazilian Society of Mastology (SBM) is at the forefront of this initiative, aiming for its implementation throughout the country.
Around 10% of cancer cases in Brazil are hereditary, according to data from the National Cancer Institute (Inca). Specifically, mutations in BRCA genes are particularly alarming. According to Rosemar Rahal, doctor and director at SBM, these mutations significantly increase the risk of breast and ovarian cancer. The test to detect these genetic mutations, funded by the SUS, is crucial to identify individuals at risk and take preventive measures, potentially saving lives.
Goiás stands out in implementing this test, in accordance with Law No. 20,707, of 2020, directing the exam to women with a family history of breast or ovarian cancer. This legislative advance is seen as a fundamental step by SBM, as it can benefit a large segment of the female population.
After mutations are identified, preventive measures, including surgeries such as mastectomy and oophorectomy, have a direct impact on patient survival. In addition to surgeries, new medications have been developed specifically for women with this genetic predisposition.
A recent agreement between the government of Goiás and the Federal University of Goiás (UFG), signed in October 2023, will allow genetic tests to be carried out at the Human Genetics Center of Goiás. UFG Institute of Biological Sciences. Initially available at the Quirinópolis Polyclinic, there are plans to expand the service to other regions of Goiás.
In addition to Goiás, other states such as Rio de Janeiro, Minas Gerais, Distrito Federal and Amazonas have legislation for genetic detection. The partnership between the government of Goiás and UFG is seen as an inspiring model for the rest of the country.
Bill No. 265/2020, under discussion at the federal level, aims to extend these genetic tests for the diagnosis and treatment of breast cancers and ovary throughout Brazil through SUS. This right has already been granted to women through private health plans since 2014. The Goiás initiative is an important step to encourage the implementation of this vital service throughout the national territory, according to Rosemar Rahal, representative of SBM.